Interesting study in this very hard to treat population MDAS positive ILD . Combined Tacrolimus and IV Cyclophosphamide have a better survival rate. But at the expense of higher risk of infections despite prophylaxis #ACR18 #CleClinicRheum https://t.co/aS0w8UQAME